Hepatocellular carcinoma with a pseudocapsule on gadolinium-enhanced MR images: correlation with histopathologic findings.

PubWeight™: 1.08‹?› | Rank: Top 10%

🔗 View Article (PMID 19095782)

Published in Radiology on December 18, 2008

Authors

Kousei Ishigami1, Kengo Yoshimitsu, Yunosuke Nishihara, Hiroyuki Irie, Yoshiki Asayama, Tsuyoshi Tajima, Akihiro Nishie, Masakazu Hirakawa, Yasuhiro Ushijima, Daisuke Okamoto, Akinobu Taketomi, Hiroshi Honda

Author Affiliations

1: Departments of Clinical Radiology, Anatomic Pathology, and Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. Ishigamikousei@aol.com

Articles citing this

CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part II. Extracellular agents, hepatobiliary agents, and ancillary imaging features. Radiology (2014) 1.33

CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part I. Development, growth, and spread: key pathologic and imaging aspects. Radiology (2014) 1.00

Primary clear cell carcinoma in the liver: CT and MRI findings. World J Gastroenterol (2011) 0.98

Differentiation of intrahepatic mass-forming cholangiocarcinoma from hepatocellular carcinoma on gadoxetic acid-enhanced liver MR imaging. Eur Radiol (2015) 0.87

Identification of the collagen type 1 α 1 gene (COL1A1) as a candidate survival-related factor associated with hepatocellular carcinoma. BMC Cancer (2014) 0.84

Focal nodular hyperplasia-like lesions in patients with cavernous transformation of the portal vein: prevalence, MR findings and natural history. Eur Radiol (2011) 0.81

Distinguishing intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma using precontrast and gadoxetic acid-enhanced MRI. Diagn Interv Radiol (2015) 0.80

Liver imaging reporting and data system (LI-RADS) version 2014: understanding and application of the diagnostic algorithm. Clin Mol Hepatol (2016) 0.80

Magnetic resonance imaging with gadoxetic acid for local tumour progression after radiofrequency ablation in patients with hepatocellular carcinoma. Eur Radiol (2016) 0.79

Added value of smooth hypointense rim in the hepatobiliary phase of gadoxetic acid-enhanced MRI in identifying tumour capsule and diagnosing hepatocellular carcinoma. Eur Radiol (2016) 0.78

Contrast Enhanced MRI in the Diagnosis of HCC. Diagnostics (Basel) (2015) 0.76

Vascular invasion in hepatocellular carcinoma: is there a correlation with MRI? Br J Radiol (2011) 0.76

Prostate cancer with a pseudocapsule at MR imaging: a marker of high grade and stage disease? Clin Imaging (2016) 0.75

MRI features of hepatocellular carcinoma related to biologic behavior. Korean J Radiol (2015) 0.75

Pathology-MRI Correlation of Hepatocarcinogenesis: Recent Update. J Pathol Transl Med (2015) 0.75

Synchronous multicentric small hepatocellular carcinomas: defining the capsule on high-frequency intraoperative ultrasonography with pathologic correlation. Ultrasonography (2016) 0.75

Ectopic blood supply of hepatocellular carcinoma as depicted by angiography with computed tomography: associations with morphological features and therapeutic history. PLoS One (2013) 0.75

Capsule, septum, and T2 hyperintense foci for differentiation between large hepatocellular carcinoma (≥5 cm) and intrahepatic cholangiocarcinoma on gadoxetic acid MRI. Eur Radiol (2017) 0.75

Articles by these authors

Characteristics of printing company workers newly diagnosed with occupational cholangiocarcinoma. J Hepatobiliary Pancreat Sci (2014) 2.22

Japanese clinical guidelines for autoimmune pancreatitis. Pancreas (2009) 2.11

Clinical significance and potential of hepatic microRNA-122 expression in hepatitis C. Liver Int (2010) 1.86

Identification of novel serum biomarkers of hepatocellular carcinoma using glycomic analysis. Hepatology (2013) 1.76

CT Hounsfield units of brown adipose tissue increase with activation: preclinical and clinical studies. J Nucl Med (2010) 1.70

Salivary gland tumors: diagnostic value of gadolinium-enhanced dynamic MR imaging with histopathologic correlation. Radiology (2003) 1.67

Risk factors for and management of delayed intraperitoneal hemorrhage after pancreatic and biliary surgery. Am J Surg (2007) 1.64

Sequential hemodynamic change in hepatocellular carcinoma and dysplastic nodules: CT angiography and pathologic correlation. AJR Am J Roentgenol (2002) 1.58

Apparent diffusion coefficients of breast tumors: clinical application. Magn Reson Med Sci (2008) 1.56

Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease. Invest Radiol (2010) 1.55

Parotid gland tumors: can addition of diffusion-weighted MR imaging to dynamic contrast-enhanced MR imaging improve diagnostic accuracy in characterization? Radiology (2008) 1.55

Risk factors that increase mortality after living donor liver transplantation. Transplantation (2012) 1.51

Assessment of graft fibrosis by transient elastography in patients with recurrent hepatitis C after living donor liver transplantation. Transplantation (2008) 1.51

Outcomes of living donor liver transplantation for hepatitis C virus-positive recipients in Japan: results of a nationwide survey. Transpl Int (2014) 1.49

Mutations in hepatitis C virus genotype 1b and the sensitivity of interferon-ribavirin therapy after liver transplantation. J Hepatol (2010) 1.48

An intraorbital wooden foreign body: description of a case and a variety of CT appearances. Emerg Radiol (2007) 1.48

Enhanced mass on contrast-enhanced breast MR imaging: Lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images. J Magn Reson Imaging (2008) 1.47

Variants in IL28B in liver recipients and donors correlate with response to peg-interferon and ribavirin therapy for recurrent hepatitis C. Gastroenterology (2010) 1.47

Angiosarcoma of the scalp treated with curative radiotherapy plus recombinant interleukin-2 immunotherapy. Int J Radiat Oncol Biol Phys (2005) 1.44

Enhanced computed tomography after partial nephrectomy in early postoperative period to detect asymptomatic renal artery pseudoaneurysm. Int J Urol (2014) 1.43

Age-related structural changes in the young adult brain shown by magnetic resonance diffusion tensor imaging. Acad Radiol (2005) 1.42

Successful prolonged rituximab treatment for post-transplant lymphoproliferative disorder following living donor liver transplantation in a child. Pediatr Transplant (2007) 1.40

Clinical significance of histone deacetylase 1 expression in patients with hepatocellular carcinoma. Oncology (2007) 1.33

Genome-wide association study identifies TNFSF15 and POU2AF1 as susceptibility loci for primary biliary cirrhosis in the Japanese population. Am J Hum Genet (2012) 1.32

The predictors of microvascular invasion in candidates for liver transplantation with hepatocellular carcinoma-with special reference to the serum levels of des-gamma-carboxy prothrombin. J Surg Oncol (2007) 1.30

Cell-free fetal DNA in maternal circulation after amniocentesis. Clin Chem (2003) 1.30

Amide proton transfer imaging of adult diffuse gliomas: correlation with histopathological grades. Neuro Oncol (2013) 1.29

Beta-TCP bone graft substitutes in a bilateral rabbit tibial defect model. Biomaterials (2008) 1.29

Living donor liver transplantation in a patient with giant hepatic hemangioma complicated by Kasabach-Merritt syndrome: report of a case. Surg Today (2008) 1.28

Arterial blood supply of hepatocellular carcinoma and histologic grading: radiologic-pathologic correlation. AJR Am J Roentgenol (2008) 1.28

Successful management of chylous ascites after living donor liver transplantation with somatostatin. Liver Int (2008) 1.28

Amendment of the Japanese Consensus Guidelines for Autoimmune Pancreatitis, 2013 III. Treatment and prognosis of autoimmune pancreatitis. J Gastroenterol (2014) 1.26

Diffusion-weighted echo-planar MR imaging and ADC mapping in the differential diagnosis of ovarian cystic masses: usefulness of detecting keratinoid substances in mature cystic teratomas. J Magn Reson Imaging (2005) 1.24

Role of tumor-associated macrophages in the progression of hepatocellular carcinoma. Surg Today (2011) 1.23

Usefulness of apparent diffusion coefficient map in diagnosing prostate carcinoma: correlation with stepwise histopathology. J Magn Reson Imaging (2008) 1.22

Diacylglycerol kinase delta regulates protein kinase C and epidermal growth factor receptor signaling. Proc Natl Acad Sci U S A (2006) 1.20

Lymphatic spread is related to VEGF-C expression and D2-40-positive myofibroblasts in intrahepatic cholangiocarcinoma. Mod Pathol (2008) 1.19

Mutator phenotype of MUTYH-null mouse embryonic stem cells. J Biol Chem (2003) 1.19

Natural history of pancreatic intraductal papillary mucinous tumor of branch duct type: follow-up study by magnetic resonance cholangiopancreatography. J Comput Assist Tomogr (2004) 1.18

MR imaging of focal medullary sponge kidney: case report. Magn Reson Med Sci (2012) 1.18

Comparison of 18FDG-PET with 99mTc-HMDP scintigraphy for the detection of bone metastases in patients with breast cancer. Ann Nucl Med (2005) 1.17

Impact of carbon ion radiotherapy for unresectable osteosarcoma of the trunk. Cancer (2012) 1.15

Bone formation and resorption of highly purified beta-tricalcium phosphate in the rat femoral condyle. Biomaterials (2005) 1.14

Helical CT of the local spread of carcinoma of the gallbladder: evaluation according to the TNM system in patients who underwent surgical resection. AJR Am J Roentgenol (2002) 1.13

Non-small cell lung cancer: detection of early response to chemotherapy by using contrast-enhanced dynamic and diffusion-weighted MR imaging. Radiology (2011) 1.12

Delayed-phase dynamic CT enhancement as a prognostic factor for mass-forming intrahepatic cholangiocarcinoma. Radiology (2005) 1.12

The beneficial role of simultaneous splenectomy in living donor liver transplantation in patients with small-for-size graft. Transpl Int (2008) 1.12

Fitz-Hugh-Curtis syndrome. Radiologic manifestation. J Comput Assist Tomogr (2003) 1.11

Newborn mass screening and selective screening using electrospray tandem mass spectrometry in Japan. J Chromatogr B Analyt Technol Biomed Life Sci (2002) 1.11

An analysis of the physiological FDG uptake pattern in the stomach. Ann Nucl Med (2003) 1.11

Rituximab, IVIG, and plasma exchange without graft local infusion treatment: a new protocol in ABO incompatible living donor liver transplantation. Transplantation (2009) 1.10

Outcomes of hepatic resection for huge hepatocellular carcinoma (≥ 10 cm in diameter). J Surg Oncol (2011) 1.10

Extended indication for living donor liver transplantation in patients with hepatocellular carcinoma. Transplantation (2007) 1.10

Prevalence of stenoocclusive lesions in the renal and abdominal arteries in moyamoya disease. AJR Am J Roentgenol (2004) 1.10

Rhabdomyolysis developing after transcatheter arterial chemoembolization for hepatocellular carcinoma. Cardiovasc Intervent Radiol (2009) 1.08

Impact of FDG-PET/CT in the management of lymphoma. Ann Nucl Med (2011) 1.08

Impact of cholesterol metabolism and the LXRalpha-SREBP-1c pathway on nonalcoholic fatty liver disease. Int J Mol Med (2009) 1.08

Phyllodes tumor of the breast: correlation between MR findings and histologic grade. Radiology (2006) 1.08

"High-risk stigmata" of the 2012 international consensus guidelines correlate with the malignant grade of branch duct intraductal papillary mucinous neoplasms of the pancreas. Pancreas (2014) 1.07

Pulmonary tumor thrombotic microangiopathy: FDG-PET/CT findings. Clin Nucl Med (2009) 1.07

Interaction between Toll-like receptors and natural killer cells in the destruction of bile ducts in primary biliary cirrhosis. Hepatology (2011) 1.07

Radiation-induced rib fractures after hypofractionated stereotactic body radiation therapy: risk factors and dose-volume relationship. Int J Radiat Oncol Biol Phys (2012) 1.06

A case of diffuse-type primary hepatic lymphoma mimicking diffuse hepatocellular carcinoma. Ann Nucl Med (2011) 1.05